In the few months since its launch in late 2013, major bottling and packaging companies in Europe and North America have rushed to deploy Smart Skin Technologies’ Quantifeel™ DRONE, an industry-first hardware and software solution to measure pressure and ensure efficient production.
SimplyCast.com, a global leader in multi-channel marketing Platform-as-a-Service solutions, today announced that the company has signed a deal with AutoSoft, a leading national dealer solutions provider, to become a preferred partner.
New technology companies based in Cape Breton and the Mulgrave area have a chance to compete in a new competition offering mentoring and funding to help them develop their products.
Spark Cape Breton, launched today, Jan. 9, is a competition that finds and supports high potential, early-stage knowledge-based companies, and encourages entrepreneurial activity in the region.
Fall 2013 Round
Researcher: Sherri A. McFarland
Project: Natural Products for Photodynamic Inactivation of Microorganisms
Capital District Health Authority
Researcher: Melanie Kelly and Mary Lynch
Project: Novel Formulation for Ocular Pain
Researcher: Christopher McMaster
Project: Toward the Development of a New Class of Gram Negative Antibiotics
Researcher: Sultan Darvesh
Project: An Early Diagnostic Marker for Alzheimer’s Disease
Halifax-based topLog has developed a way to help detect, prevent and fix costly information technology system issues.
With an equity investment from Innovacorp, Nova Scotia's early-stage venture capital organization, topLog will finish developing and test its product in the next few months.
Halifax-based CarbonCure Technologies Inc. announced today that it has closed a $3.5 million Series B financing round led by BDC Venture Capital. Other investors include Eagle Cliff Partners, Innovacorp, 350 Capital and strategic investors.
Proceeds from the current round of funding will accelerate the company’s growth by expanding the technology application from masonry to precast and ready mix, and further increase its customer base across North America.
Immunovaccine Inc. (“Immunovaccine” or “IMV”) (TSX-V: IMV), a clinical stage vaccine and immunotherapy company, has closed the previously announced private placement of its securities, raising gross proceeds of $4.2 million (the “Private Placement”). Under terms of the financing, a total of 10,511,209 common shares (the “Common Shares”) of Immunovaccine were sold at a price of $0.40 per Common Share.
Net proceeds from the Offering will be used for general corporate purposes.
The following I-3 Technology Start-Up Competition participants have been invited to compete in round two:
Zone 1 (Cumberland, Colchester, Pictou, Antigonish and Guysborough counties)
Innovacorp today announced the list of Nova Scotia start-ups moving on to round two of the I-3 Technology Start-Up Competition.
“We were incredibly impressed by the caliber of submissions we received this year from across the province and across a variety of technology sectors,” said Stephen Duff, president and CEO of Innovacorp. “It made for very challenging work for the judges in each of the five I-3 zones. We are grateful for the enthusiasm and participation of all the I-3 competition entrants, and we offer our congratulations to the finalists in each zone.”
Halifax-based DeCell Technologies Inc. has come up with a better way to produce skin grafts for wound treatment.
With an equity investment from Innovacorp, Nova Scotia's early-stage venture capital organization, DeCell will complete the development and human testing of its first product for the treatment of diabetic foot ulcers.